The United States has taken a major step in changing how it treats cannabis. The US Department of Justice has officially reclassified marijuana, marking a historic shift in the country’s drug policy.

Justice Department to expedite broader marijuana rescheduling hearing Move expected to boost cannabis industry by easing taxes and funding access Prior classification equated it with drugs like heroin ...

The Trump Administration has designed a Most-Favored-Nation (MFN) drug pricing policy framework to address the major differences in drug prices and contributions to the pharmaceutical innovation ...

The authors argue that sustainable drug pricing reform should focus on patient-centered value, not price alone. IRP is a government price-control mechanism utilized worldwide, where a country ...

In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in peer countries, according to an AARP Public Policy Institute report ...